Facebook
Linkedin
Mail
Twitter
Youtube
Home
Latest News
Features
Structural Heart
Profiles
Videos
Events
Supplements
Past Issues
Subscribe
Search
Facebook
Linkedin
Mail
Twitter
Youtube
Cardiovascular News
Home
Latest News
Features
Structural Heart
Profiles
Videos
Events
Supplements
Past Issues
Subscribe
Tag: ADA 2025
ADA 2025: Semaglutide taken orally shown to reduce cardiovascular risk in type 2 diabetes patients
23rd June 2025
Research presented at the American Diabetes Association (ADA) 2025 scientific session (20–23 June, C...